MASTL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.490400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.070400E-01
Normal-vs-Stage2
8.231600E-01
Normal-vs-Stage3
1.252000E-01
Normal-vs-Stage4
7.997000E-01
Stage1-vs-Stage2
9.007600E-01
Stage1-vs-Stage3
1.981030E-01
Stage1-vs-Stage4
7.018000E-01
Stage2-vs-Stage3
1.721050E-01
Stage2-vs-Stage4
5.788600E-01
Stage3-vs-Stage4
6.545900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.475800E-01
Normal-vs-AfricanAmerican
8.339600E-01
Normal-vs-Asian
6.505200E-01
Caucasian-vs-AfricanAmerican
4.688400E-01
Caucasian-vs-Asian
6.382000E-01
AfricanAmerican-vs-Asian
4.094200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.890600E-01
Normal-vs-Female
9.710200E-01
Male-vs-Female
1.054430E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.906800E-01
Normal-vs-Age(41-60Yrs)
9.931000E-01
Normal-vs-Age(61-80Yrs)
6.254800E-01
Normal-vs-Age(81-100Yrs)
6.111600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.689600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.861400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.855400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.208400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.262000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.477800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.306600E-01
Normal-vs-Daily Drinker
6.226400E-01
Normal-vs-Weekly Drinker
9.823200E-01
Normal-vs-Occasional Drinker
7.018600E-01
Normal-vs-Social Drinker
3.901400E-01
Non Drinker-vs-Daily Drinker
8.415200E-01
Non Drinker-vs-Weekly Drinker
3.875600E-01
Non Drinker-vs-Occasional Drinker
6.792000E-01
Non Drinker-vs-Social Drinker
7.845400E-01
Daily Drinker-vs-Weekly Drinker
4.514000E-01
Daily Drinker-vs-Occasional Drinker
8.005200E-01
Daily Drinker-vs-Social Drinker
5.994200E-01
Weekly Drinker-vs-Occasional Drinker
5.843800E-01
Weekly Drinker-vs-Social Drinker
3.091400E-01
Occasional Drinker-vs-Social Drinker
4.389000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.959800E-01
Normal-vs-Grade 2
9.429200E-01
Normal-vs-Grade 3
9.566600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.353100E-04
Grade 1-vs-Grade 3
1.695220E-03
Grade 1-vs-Grade 4
7.959800E-01
Grade 2-vs-Grade 3
7.668800E-01
Grade 2-vs-Grade 4
9.429200E-01
Grade 3-vs-Grade 4
9.566600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.578600E-01
Normal-vs-NonDiabetic
7.280200E-01
Diabetic-vs-NonDiabetic
3.909600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.969600E-01
Normal-vs-NoPancreatitis
6.703800E-01
Pancreatitis-vs-NoPancreatitis
8.388000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.794000E-01
Normal-vs-N1
8.282000E-01
N0-vs-N1
4.169000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.145400E-01
Normal-vs-TP53-NonMutant
5.539600E-01
TP53-Mutant-vs-TP53-NonMutant
1.682760E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
